Flovent Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Funding
• Alerts
• Clinical Trials

A Bioequivalence Study Between Fluticasone and Salmeterol vs. SERETIDE DISKUS ® in Healthy Volunteers With Charcoal Blockade
Condition:   Bioequivalence Interventions:   Drug: Test Product (Fluticasone propionate and salmeterol xinafoate inhalation powder/Respirent Pharmaceuticals);   Drug: Reference Product (SERETIDE DISKUS® 100/50 inhalation powder/GSK);   Other: Activated Charcoal suspension Sponsors:   Respirent Pharmaceuticals Co Ltd.;   BECRO Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 11, 2019 Category: Research Source Type: clinical trials